ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02
Published December 17, 2014 · Recall initiated: September 27, 2012
Summary
FDA records drug Class II recall D-0296-2015, published December 17, 2014 and initiated September 27, 2012. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 184,550 Vials; Lot: Lot 6003930, exp. date 04/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
What to do
Voluntary: Firm initiated · Letter
Get an email if ONDANSETRON has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ONDANSETRON
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- U.S. Nationwide Including Puerto Rico
- UPC
- 0363323374204
- Lot
- Lot 6003930, exp. date 04/2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOndansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets),January 7, 2026
- FDAMIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APPDecember 17, 2014
- FDACYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APPDecember 17, 2014
- FDAFentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only, 25December 17, 2014
- FDAOndansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., LakeNovember 27, 2013
- FDAOndansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDCAugust 14, 2013
Questions about this recall
Was ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02 recalled?
Yes. FDA published recall D-0296-2015 on December 17, 2014. Reported hazard: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ONDANSETRON. UPC: 0363323374204.